Sawai Usa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAWAI USA, and what generic and branded alternatives to SAWAI USA drugs are available?
SAWAI USA has three approved drugs.
Summary for Sawai Usa
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
| PTAB Cases with Sawai Usa as petitioner: | See PTAB cases with Sawai Usa as petitioner |
Drugs and US Patents for Sawai Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sawai Usa | PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205955-003 | Feb 3, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sawai Usa | DIMETHYL FUMARATE | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 210285-002 | Dec 21, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sawai Usa | MIRABEGRON | mirabegron | TABLET, EXTENDED RELEASE;ORAL | 209446-001 | Dec 27, 2019 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sawai Usa | PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205955-001 | Feb 3, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Sawai Usa | DIMETHYL FUMARATE | dimethyl fumarate | CAPSULE, DELAYED RELEASE;ORAL | 210285-001 | Dec 21, 2021 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sawai Usa | PITAVASTATIN CALCIUM | pitavastatin calcium | TABLET;ORAL | 205955-002 | Feb 3, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
